Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases.
Hanna WesslauAnders CarlanderLars NyFredrik WärnbergRoger Olofsson BaggeAnn-Sophie Lindqvist BaggePublished in: Cancers (2022)
For patients with melanoma ITMs, the female sex and higher tumor burden (i.e., number of tumors) were significantly correlated with lower HRQOL. However, these findings do not fully explain HRQOL for this patient population, and future research should consider the possibility that there are specific questions for patients with ITM where current instruments might fail to measure their discomfort to the full extent.